Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
480.80    -0.20 (-0.04%)
Bid:
480.60
Ask:
481.00
Spread: 0.40 (0.083%)
Market Cap: £1.30b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Trading Update

27 Nov 2012 07:00

RNS Number : 0473S
Chemring Group PLC
27 November 2012
 



 

 

FOR IMMEDIATE RELEASE 27 November 2012

 

CHEMRING GROUP PLC

 

 Trading Update

 

 

Chemring Group PLC ("Chemring" or "the Group") today provides an update on trading having entered the close period in respect of its preliminary results for the financial year ended 31 October 2012.

 

Trading

 

The Group's performance during 2012 was extremely disappointing. Chemring's operational performance has been weak, and management of investors' expectations over the past year has also been poor. In part, this resulted from a failure to anticipate the likely impact of the changing market dynamics on the Group's businesses, but also reflected failures in performance at several of our businesses.

 

Expectations for the Group's trading performance for the financial year ended 31 October 2012 remain in line with the trading update issued on 1 November 2012. The following further detail is subject to final audit.

 

Trading in the final quarter was impacted by the issues set out in the 1 November 2012 trading statement that principally affected the Countermeasures and Munitions business segments. As a result, turnover for the financial year ended 31 October 2012 is expected to be approximately £740 million (2011: £725 million).

 

The year end order book of approximately £760 million compares to £878.3 million at the prior year end.

 

Financial position

 

There was a significant operating cash inflow in the final quarter that resulted in net debt at the year end of approximately £250 million. (2011: £262.7 million).

 

Market conditions

 

Defence spending in the US, UK and Europe is expected to remain under significant pressure.

 

The US defence market remains vulnerable to ongoing budget uncertainties, particularly around sequestration and the impact of a six month continuing resolution from 1 October 2012. The threat of sequestration continues to have a negative impact on customer behaviour, and there is a lack of clarity about defence expenditure in the medium term. As a result, we are seeing delays in the procurement process whilst customers await greater visibility and certainty as to their future budgets.

 

The UK MoD's review of its procurement process continues to result in delays to the start of new programmes and reduced funding for existing ones whilst, in Europe, ongoing deficit reduction programmes are exerting downward pressure on defence spending, leading to uncertainty in the procurement process and delayed programme implementation.

 

Chemring's non-NATO markets continue to offer opportunities, although order intake remains subject to the granting of export licence approval, which is proving more difficult to achieve in some markets.

 

Outlook

 

The wider market backdrop is likely to remain challenging. Chemring needs to adapt and better equip itself in order to meet these challenges.

 

Mark Papworth joined Chemring as Chief Executive Officer on 5 November 2012, and brings significant experience of delivering performance improvement and implementation of strategic change in the manufacturing, technology and service sectors. He will present his initial views on Chemring and his operational priorities at the Group's preliminary results which are expected to be announced on 24 January 2013.

 

 

- Ends -

 

 

A conference call for analysts and investors will be held at 08.30 GMT today. Dial-in details are as follows:

 

Participant dial in: +44 (0)20 3140 0668 (toll) / 0800 368 1950 (toll free)

PIN: 475152#.

 

A playback facility will be available for 30 days. Dial-in details are 020 3140 0698/0800 368 1890

PIN: 388348#

 

 

For further information:

 

Chemring Group PLC:

 

Rupert Pittman Director of Communications 01489 881 880

& Investor Relations rupertp@chemring.co.uk

 

MHP Communications:

 

Andrew Jaques / John Olsen / James White 0203 128 8100

chemringplc@mhpc.com

 

Cautionary statement: 

 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements.

 

There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects.

 

Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBKADNOBDDCDB
Date   Source Headline
2nd Jan 201512:59 pmRNSTotal Voting Rights
30th Dec 20147:00 amRNSDirectorate Change
19th Dec 201410:26 amRNSBlocklisting Interim Review
1st Dec 20141:26 pmRNSHolding(s) in Company
1st Dec 20141:22 pmRNSTotal Voting Rights
25th Nov 20147:00 amRNSPOST-CLOSE STATEMENT
3rd Nov 20142:36 pmRNSTotal Voting Rights
1st Oct 201410:04 amRNSTotal Voting Rights
17th Sep 20147:00 amRNSInterim Management Statement
1st Sep 20142:52 pmRNSTotal Voting Rights
8th Aug 201412:28 pmRNSDirector/PDMR Shareholding
1st Aug 201410:34 amRNSTotal Voting Rights
21st Jul 201410:03 amRNSDirector/PDMR Shareholding
9th Jul 201411:57 amRNSDirector/PDMR Shareholding
2nd Jul 20147:30 amRNSHolding(s) in Company
1st Jul 201412:10 pmRNSDirector/PDMR Shareholding
1st Jul 20149:38 amRNSHolding(s) in Company
1st Jul 20149:00 amRNSChange of Registered Office
24th Jun 20147:00 amRNSDirectorate Change
24th Jun 20147:00 amRNSHalf Yearly Report
18th Jun 201411:00 amRNSBlocklisting Interim Review
30th May 20144:59 pmRNSTotal Voting Rights
27th May 20143:29 pmRNSHolding(s) in Company
27th May 20142:37 pmRNSCompletion of Disposal of European Munitions
22nd May 20147:00 amRNSUpdate on Disposal
12th May 20149:40 amRNSResult of EGM
9th May 20147:00 amRNSACQUISITION OF 3D-RADAR
1st May 201412:18 pmRNSTotal Voting Rights
30th Apr 201411:34 amRNSDirector/PDMR Shareholding
29th Apr 20141:20 pmRNSDirector/PDMR Shareholding
29th Apr 201412:42 pmRNSPDMR Shareholding
29th Apr 201411:59 amRNSDirector/PDMR Shareholding
29th Apr 201411:58 amRNSDirector/PDMR Shareholding
29th Apr 201411:57 amRNSDirector/PDMR Shareholding
29th Apr 201411:14 amRNSHolding(s) in Company
24th Apr 20144:30 pmRNSPublication of Circular
24th Apr 20147:00 amRNSDisposal
15th Apr 201412:11 pmRNSDirector Declaration
14th Apr 201411:15 amRNSBlocklisting update
9th Apr 201410:12 amRNSAdditional Listing
26th Mar 20144:16 pmRNSDoc re. Ordinary & Special Resolutions
20th Mar 20142:04 pmRNSResult of AGM
3rd Mar 201410:11 amRNSTotal Voting Rights
27th Feb 20147:00 amRNSInterim Management Statement
6th Feb 201412:18 pmRNSHolding(s) in Company
3rd Feb 201410:43 amRNSTotal Voting Rights
3rd Feb 201410:37 amRNSHolding(s) in Company
31st Jan 20144:19 pmRNSHolding(s) in Company
30th Jan 20145:10 pmRNSHolding(s) in Company
29th Jan 20145:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.